With generous funding from donors, Greenwich Hospital purchased the Paxman Scalp Cooling System that can potentially reduce hair loss associated with chemotherapy in breast cancer patients.
Chemotherapy targets all rapidly dividing cells in the body, with hair cells among the fastest-dividing. This is why many chemotherapy drugs cause hair loss.
With this new system, patients wear a cooling cap on their heads before, during and after chemo treatment. Scalp cooling reduces the damage to hair follicles by cooling the scalp, which reduces blood flow to the area around the hair follicles to possibly prevent or minimize hair loss. Scalp cooling does not reduce hair loss on other parts of the body.
In 2017, the Food and Drug Administration approved the Paxman system as a prescriptive device to reduce hair loss for breast cancer patients. While success rates vary and depend on the chemotherapy regimen, studies show patients who use scalp cooling tend to lose less hair, and use head coverings or wigs less often.